Menu
/REGISTER
Montecito
Pac Premier
Loading...
You are here:  Home  >  'FDA'  -  Page 13
Latest

Vapor Hub hopes to lead the way in $3B e-cigarette market

By   /  Friday, May 9th, 2014  /  East Ventura County, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Vapor Hub hopes to lead the way in $3B e-cigarette market

With the U.S. Food and Drug Administration promising to impose regulations on the free-for-all e-cigarette market, Simi Valley-based Vapor Hub International is hoping to help the industry grow up.

Read More →
Latest

Amgen braces for biosimilars rules

By   /  Friday, October 7th, 2011  /  Banking & Finance, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen braces for biosimilars rules

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen expects approval for Xgeva as bone treatment in April

By   /  Monday, August 22nd, 2011  /  Banking & Finance, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen expects approval for Xgeva as bone treatment in April

Thousand Oaks-based Amgen said Aug. 22 that the U.S. Food and Drug Administration will likely make a decision by April 26, 2012 on the biotech firm’s application to expand the use of its Xgeva bone treatment drug to treat advanced prostate cancer. Amgen, the largest biotech company in the world, said in a statement that Read More →

Read More →
Latest

Amgen gets sought-after FDA approval

By   /  Thursday, November 18th, 2010  /  Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen gets sought-after FDA approval

The Food and Drug Administration has approved the use of Amgen’s bone drug denosumab in patients with certain types of cancer, Amgen announced Nov. 18.

Read More →
Latest

FDA OKs Aranesp for pre-dialysis patients

By   /  Monday, October 25th, 2010  /  Latest news, Technology  /  Comments Off on FDA OKs Aranesp for pre-dialysis patients

Amgen’s anemia treatment Aranesp is safe for kidney patients whose disease doesn’t require dialysis, a federal panel announced Oct. 18 in response to a study that found the drug could increase stroke risk in those patients. Outside advisers to the U.S. Food and Drug Administration said the treatment shouldn’t be withdrawn or limited to a Read More →

Read More →